Corvus Pharmaceuticals Inc buy LADENBURG THALM/SH SH
Start price
16.09.24
/
50%
€5.26
Target price
16.09.25
€18.87
Performance (%)
-11.31%
End price
17.09.25
€4.67
Summary
This prediction ended on 17.09.25 with a price of €4.67. The price of Corvus Pharmaceuticals Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.31%. LADENBURG_THALM_SH_S has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | 24.377% | 24.377% | 45.473% |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% |
Comments by LADENBURG_THALM_SH_S for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target raised by analysts at LADENBURG THALM/SH SH from $12.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von LADENBURG_THALM_SH_S gewählte maximale Laufzeit wurde überschritten